A CRF2 agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats

Brain Research

Volumn 1155, Issue 1, 2007, Pages 172-178

  Funk, Cindy K ^a   Koob, George F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Alcohol; Corticotropin releasing factor receptor; Dependence; Self administration; Urocortin; Withdrawal

Indexed keywords

ALCOHOL; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; RECEPTOR SUBTYPE; UROCORTIN III;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; EMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

ALCOHOL DRINKING; ALCOHOLISM; AMYGDALA; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DRINKING BEHAVIOR; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SELF ADMINISTRATION; WATER;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 34250175137     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.04.009     Document Type: Article

References (61)

1. Bakshi V.P., Smith-Roe S., Newman S.M., Grigoriadis D.E., and Kalin N.H. Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala. J. Neurosci. 22 (2002) 2926-2935
2. Baldwin H.A., Rassnick S., Rivier J., Koob G.F., and Britton K.T. CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology 103 (1991) 227-232
3. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E., Koob G.F., Vale W.W., and Lee K.F. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet. 24 (2000) 410-414
4. Bale T.L., and Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 525-557
5. Becker H.C., and Lopez M.F. Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL/6 mice. Alcohol.: Clin. Exp. Res. 28 (2004) 1829-1838
6. Bloom F.E., Battenberg E.L., Rivier J., and Vale W. Corticotropin-releasing factor (CRF): Immunoreactive neurones and fibers in rat hypothalamus. Regul. Pept. 4 (1982) 43-48
7. Breese G.R., Knapp D.J., and Overstreet D.H. Stress sensitization of ethanol withdrawal-induced reduction in social interaction: inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A-receptor agonist. Neuropsychopharmacology 29 (2004) 470-482
8. Chang C.P., Pearse R.V.n., O'Connell S., and Rosenfeld M.G. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11 (1993) 1187-1195
9. Chen R., Lewis K.A., Perrin M.H., and Vale W.W. Expression cloning of a human corticotropin-releasing factor receptor. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 8967-8971
10. Dunn A.J., and Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res. Rev. 15 (1990) 71-100
11. Fekete E.M., and Zorrilla E.P. Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front. Neuroendocrinol. 28 (2007) 1-27
12. Fekete E.M., Inoue K., Zhao Y., Rivier J.E., Vale W.W., Szucs A., Koob G.F., and Zorrilla E.P. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval. Neuropsychopharmacology 32 (2007) 1052-1068
13. Funk C.K., O'Dell L.E., Crawford E.F., and Koob G.F. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J. Neurosci. 26 (2006) 11324-11332
14. Funk C.K., Zorrilla E.P., Lee M.J., Rice K.C., and Koob G.F. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol. Psychiatry 61 (2007) 78-86
15. Heinrichs S.C., Lapsansky J., Lovenberg T.W., De Souza E.B., and Chalmers D.T. Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior. Regulatory Peptides 71 (1997) 15-21
16. Hershon H.I. Alcohol withdrawal symptoms and drinking behavior. J. Stud. Alcohol 38 (1977) 953-971
17. Ho S.P., Takahashi L.K., Livanov V., Spencer K., Lesher T., Maciag C., Smith M.A., Rohrbach K.W., Hartig P.R., and Arneric S.P. Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor. Brain Res. Mol. Brain Res. 89 (2001) 29-40
18. Kishimoto T., Radulovic J., Radulovic M., Lin C.R., Schrick C., Hooshmand F., Hermanson O., Rosenfeld M.G., and Spiess J. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat. Genet. 24 (2000) 415-419
19. Koob G.F. Neuroadaptive mechanisms of addiction: studies on the extended amygdala. Eur. Neuropsychopharmacol. 13 (2003) 442-452
20. Koob G.F., Ahmed S.H., Boutrel B., Chen S.A., Kenny P.J., Markou A., O'Dell L.E., Parsons L.H., and Sanna P.P. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci. Biobehav. Rev. 27 (2004) 739-749
21. LeDoux J.E., Iwata J., Cicchetti P., and Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J. Neurosci. 8 (1988) 2517-2529
22. Liebsch G., Landgraf R., Gerstberger R., Probst J.C., Wotjak C.T., Engelmann M., Holsboer F., and Montkowski A. Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul. Pept. 59 (1995) 229-239
23. Liebsch G., Landgraf R., Engelmann M., Lorscher P., and Holsboer F. Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain. J. Psychiatr. Res. 33 (1999) 153-163
24. Liu J., Yu B., Neugebauer V., Grigoriadis D.E., Rivier J., Vale W.W., Shinnick-Gallagher P., and Gallagher J.P. Corticotropin-releasing factor and urocortin I modulate excitatory glutamatergic synaptic transmission. J. Neurosci. 24 (2004) 4020-4029
25. Liu J., Yu B., Orozco-Cabal L., Grigoriadis D.E., Rivier J., Vale W.W., Shinnick-Gallagher P., and Gallagher J.P. Chronic cocaine administration switches corticotropin-releasing factor2 receptor-mediated depression to facilitation of glutamatergic transmission in the lateral septum. J. Neurosci. 25 (2005) 577-583
26. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., and Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 836-840
27. Menzaghi F., Rassnick S., Heinrichs S., Baldwin H., Pich E.M., Weiss F., and Koob G.F. The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal. Ann. N. Y. Acad. Sci. 739 (1994) 176-184
28. Merchenthaler I., Vigh S., Petrusz P., and Schally A.V. Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain. Am. J. Anat. 165 (1982) 385-396
29. Merlo Pich E., Lorang M., Yeganeh M., Rodriquez de Fonseca F., Raber J., Koob G.F., and Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15 (1995) 5439-5447
30. Moller C., Wiklund L., Sommer W., Thorsell A., and Heilig M. Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions. Brain Res. 760 (1997) 94-101
31. Muller M.B., Zimmerman S., Sillaber I., Hagemeyer T.P., Deussing J.M., Timpl P., Kormann M.S.D., Droste S.K., Kuhn R., Reul J.M.H.M., Holsboer F., and Wurst W. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat. Neurosci. 6 (2003) 1100-1107
32. O'Dell L.E., Roberts A.J., Smith R.T., and Koob G.F. Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure. Alcohol.: Clin. Exp. Res. 28 (2004) 1676-1682
33. Overstreet D.H., Knapp D.J., and Breese G.R. Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals. Alcohol.: Clin. Exp. Res. 26 (2002) 1259-1268
34. Overstreet D.H., Knapp D.J., and Breese G.R. Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors. Pharmacol. Biochem. Behav. 77 (2004) 405-413
35. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, San Diego
36. Pelleymounter M.A., Joppa M., Ling N., and Foster A.C. Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress. J. Pharmacol. Exp. Ther. 302 (2002) 145-152
37. Pelleymounter M.A., Joppa M., Ling N., and Foster A.C. Behavioral and neuroendocrine effects of the selective CRF2 receptor agonists urocortin II and urocortin III. Peptides 25 (2004) 659-666
38. Perrin M.H., Donaldson C.J., Chen R., Lewis K.A., and Vale W.W. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 133 (1993) 3058-3061
39. Rasmussen D.D., Mitton D.R., Green J., and Puchalski S. Chronic daily ethanol and withdrawal: 2. Behavioral changes during prolonged abstinence. Alcohol.: Clin. Exp. Res. 25 (2001) 999-1005
40. Rassnick S., Heinrichs S.C., Britton K.T., and Koob G.F. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 605 (1993) 25-32
41. Rimondini R., Arlinde C., Sommer W., and Heilig M. Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. FASEB J. 16 (2002) 27-35
42. Risbrough V.B., Hauger R.L., Pelleymounter M.A., and Geyer M.A. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology (Berl) 170 (2003) 178-187
43. Risbrough V.B., Hauger R.L., Roberts A.L., Vale W.W., and Geyer M.A. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. J. Neurosci. 24 (2004) 6545-6552
44. Roberts A.J., Heyser C.J., and Koob G.F. Operant self-administration of sweetened versus unsweetened ethanol: effects on blood alcohol levels. Alcohol.: Clin. Exp. Res. 23 (1999) 1151-1157
45. Roberts A.J., Heyser C.J., Cole M., Griffin P., and Koob G.F. Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology 22 (2000) 581-594
46. Roelofs S.M.G.J. Hyperventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal syndrome. Alcohol 2 (1985) 501-505
47. Samson H.H. Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and water-sated rats. Alcoholism: Clinical and Experimental Research 10 (1986) 436-442
48. Schmitt U., Waldhofer S., Weigelt T., and Hiemke C. Free-choice ethanol consumption under the influence of GABAergic drugs in rats. Alcohol.: Clin. Exp. Res. 26 (2002) 457-462
49. Smith G.W., Aubry J.M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., Chen R., Marchuk Y., Hauser C., Bentley C.A., Sawchenko P.E., Koob G.F., Vale W., and Lee K.F. Corticotropin-releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20 (1998) 1093-1102
50. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M.H.M., Stalla G.K., Blanquet V., Steckler T., Holsboer F., and Wurst W. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat. Genet. 19 (1998) 162-166
51. Valdez G.R., and Koob G.F. Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol. Biochem. Behav. 79 (2004) 671-689
52. Valdez G.R., Inoue K., Koob G.F., Rivier J., Vale W., and Zorrilla E.P. Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Res. 943 (2002) 142-150
53. Valdez G.R., Roberts A.J., Chan K., Davis H., Brennan M., Zorrilla E.P., and Koob G.F. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol.: Clin. Exp. Res. 26 (2002) 1494-1501
54. Valdez G.R., Zorrilla E.P., Rivier J., Vale W.W., and Koob G.F. Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist. Brain Res. 980 (2003) 206-212
55. Valdez G.R., Sabino V., and Koob G.F. Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation. Alcohol.: Clin. Exp. Res. 28 (2004) 865-872
56. Vale W., Spiess J., Rivier C., and Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213 (1981) 1394-1397
57. Van Pett K., Viau V., Bittencourt J.C., Chan R.K.W., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., and Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 428 (2000) 191-212
58. Venihaki M., Sakihara S., Subramanian S., Dikkes P., Weninger S.C., Liapakis G., Graf T., and Majzoub J.A. Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: modulation by stress and attenuation of some anxiety-like behaviours. J. Neuroendocrinol. 16 (2004) 411-422
59. Walker D.L., and Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J. Neurosci. 17 (1997) 9375-9383
60. Zorrilla E.P., and Koob G.F. The therapeutic potential of CRF1 antagonists for anxiety. Exp. Opin. Invest. Drugs 13 (2004) 799-828
61. Zorrilla E.P., Valdez G.R., and Weiss F. Changes in levels of regional CRF-like immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology 158 (2001) 374-381